Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best affordable healthcare stocks to buy now. Teva ...

Prague-based Pale Fire Capital SE added 639,162 shares of Teva in the third quarter. As of September 30, the fund reported ...

The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment to financial ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Teva Pharmaceutical Industries wasn’t one of them. The 10 stocks that ...

Amid a reorganization campaign that’s breathed new life into hybrid generic and innovative medicines player Teva, the company is leaning into novel medicines and formulations more than ever and ...

Corcept Therapeutics faces high binary risk from an imminent Teva lawsuit decision that could impact Korlym sales. Find out ...

Teva stock climbs past $30 with strong Austedo and Ajovy sales, but shifting Wall Street sentiment may affect its outlook.

As the biopharma industry moves into the new year, Teva is looking to put the past behind it. After proposing a blockbuster $4.25 billion opioid settlement, the drugmaker has secured participation ...

Teva Pharmaceutical Industries is launching its first global innovation platform, challenging startups to submit novel strategies to tackle seven pervasive industry hurdles that run the gamut from ...

Investing.com -- S&P Global Ratings has upgraded Teva Pharmaceutical Industries Ltd. to ’BB+’ from ’BB’ with a stable outlook ...

S&P upgraded Teva to BB+ and Moody's turned positive, citing falling leverage, stronger cash flow, and branded drug momentum that could support a future investment-grade rating.

An Israel-based pharmaceutical company has agreed to an $85 million settlement with the state of Oklahoma over its alleged role in fueling the opioid crisis. Oklahoma Attorney General Mike Hunter had ...